1. Vantage 095: vorinostat in combination with bortezomib in salvage multiple myeloma patients: final study results of a global phase 2b trial;Siegel;Blood (ASH Annu Meet Abstr),2011
2. Phase II, randomized, double blind, placebo-controlled study comparing siltuximab plus bortezomib versus bortezomib alone in pts with relapsed/refractory multiple myeloma;Orlowski;ASCO Annu Meet Abstr,2012
3. Single-dose intravenous melphalan in advanced multiple myeloma;Back;Acta Haematol,1990
4. Single-agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma;Kumar;Bone Marrow Transpl,2004
5. Response adapted therapy using single-agent lenalidomide in older adults with newly diagnosed standard risk multiple myeloma;Baz;Blood (ASH Annu Meet Abstr),2012